Bank Of America Corp Apellis Pharmaceuticals, Inc. Put Options Transaction History

Bank Of America Corp

  • $1.19 Trillion
  • Q3 2024

Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$37.14 - $64.82 $2.37 Million - $4.14 Million
63,900 Added 396.89%
80,000 $4.79 Million
Q2 2023

Aug 14, 2023
BUY
$76.68 - $93.31 $1.23 Million - $1.5 Million
16,100 New
16,100 $1.47 Million
Q3 2021

Nov 15, 2021
BUY
$31.4 - $69.84 $3.34 Million - $7.44 Million
106,500 New
106,500 $3.51 Million

Others Institutions Holding APLS

# of Institutions
309
Shares Held
115M
Call Options Held
3.85M
Put Options Held
1.09M
View Full List

About Apellis Pharmaceuticals, Inc.

APLS Quotes by TradingView
  • Ticker APLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 109,865,000
  • Market Cap $3.05B
  • Description
  • Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...
More about APLS
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email